Literatur

Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

In: BMC Complement. Altern. Med. 10, S. 13.

Weitere Veröffentlichungen:

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

Weitere Informationen

Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917. A controlled pilot trial.

Weitere Informationen

NF-KappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917. A novel effect of a probiotic bacterium.

Weitere Informationen

Matthes, H.; Krummenerl, T.; Giensch, M.; Wolff, C.; Schulze, J. (2010): Clinical trial. Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).